MedTrace Logo

Efficacy of the Female Athlete Body Project (FAB)

NCT01735994 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 481

Last updated 2019-12-04

Study results available
· View outcomes & findings →

Summary

Given the cost of treating eating disorders and the substantial morbidity and mortality associated with these disorders, prevention of eating disorders has considerable public health significance. Female athletes represent an important population for prevention due to their risk for the Female Athlete Triad, which includes inadequate energy intake, irregular or cessation of menses, and osteoporosis. The proposed randomized controlled trial will provide important information regarding the efficacy, acceptability, and feasibility of implementing a brief eating disorder prevention and healthy living program within an existing social system of female athletes.

Conditions

Interventions

BEHAVIORAL

Healthy Weight

Eating Disorder Prevention Program for Athletes

OTHER

Brochure

Brochure on the Female athlete triad

Sponsors & Collaborators

  • National Institute of Mental Health (NIMH)

    collaborator NIH

  • Pennington Biomedical Research Center

    lead OTHER

Principal Investigators

  • Tiffany M Stewart, PhD · Pennington Biomedical

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2012-11-30
Primary Completion
2018-12-31
Completion
2018-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01735994 on ClinicalTrials.gov